Nino Marzella
Associate Professor of Pharmacy Practice
B.S., Pharm.D., Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University
nino.marzella@liu.edu
Specialties
Areas of specialty include critical care (medical intensive care) and infectious diseases pharmacotherapy.
Publications
Sorbera M, Chung E, Ho CW, Marzella N. Ceftolozane/Tazobactam: A New Option in the Treatment of Complicated Gram-Negative Infections”, Pharmacy and Therapeutics. 2014 Dec; 39(12): 825, 828-832. (In-print)
Lonie JM, Marzella N, Perry R, Shah B, Jariwala J. Pharmacists Levels of Emotionality and Career Success Correlates: An Exploratory Study”, J Pharm Pract 2014 Feb 11. Epub 2014 Feb 11. (In-print)
Rattu MA, Shah N , Lee JM, Pham AQ, Marzella N. Glucarpidase (Voraxaze), a Carboxypeptidase Enzyme for Methotrexate Toxicity”, Pharmacy and Therapeutics. Dec 2013; 38(12): 732, 741-744. (In-print)
Rattu MA, Shah N, Marzella N. The Role of Pharmacists in Tetanus Management and Prevention”, US Pharm. 2013; 38 (5): 39-52. (In-print)
Rattu MA, Shah N, Singhal S, Marzella N., The Role of Pharmacists in the Management of Acute Kidney Stones”, US Pharm. 2013; 38 (8): HS4-HS8. (In-print)
Rivkin A, Yin H, Borno L, Fabbio K, Kugler A, Maltz FN, Marzella N, Mehta M, Najib JW. “Revising senior pharmacy grand rounds to incorporate longitudinal board review to prepare students for licensing examination”, Currents in Pharmacy Teaching and Learning Volume 5, Issue 3, Pages 236–240, May–June; 2013. (In-print)
Plotkin P, Patel K, Uminski A, Marzella N. “Telavancin (Vibativ), a New Option for the Treatment of Gram-Positive Infections.” Pharmacy and Therapeutics. March 2011; 36 (3): pages 127-128, 133-138. (In-print)
Other Publications
Yaloumis M, Korobova N, Patel Y, Marzella N. Innovative Antimicrobial Avycaz® (ceftazidime-avibactam). NYHHCS Pharmacy Newsletter. Volume 1; Issue 21: Summer 2015. (In-print)
Rothberger N, Askarinam L, Akhand T, Marzella N. Pseudobulbar Affect (PBA): Role of Neudexta® NYHHCS Pharmacy Newsletter. Volume 1; Issue 18: Fall 2014. (In-print)
Sivkov A, Marzella N. Procalcitonin – A marker for infection? NYHHCS Pharmacy Newsletter. Volume 1; Issue 7: September/October 2012. (In-print)
Rosner D, Koslowsky A, Marzella N. Azithromycin – Risk of Cardiovascular Death. NYHHCS Pharmacy Newsletter. Volume 1; Issue 6: July/August 2012. (In-print)
Scarlino L, Marzella N. Roflumilast (Daliresp®). NYHHCS Pharmacy Newsletter. Volume 1; Issue 2: November/December 2011. (In-print)
Shmayenik A, Marzella N. Fidaxomicin (Dificid®). NYHHCS Pharmacy Newsletter. Volume 1; Issue 2: November/December 2011. (In-print)
Lectures and Presentations
Rattu MA, Marzella N, et al. , “Effects of chronic oral proton pump inhibitor therapy on serum magnesium and calcium levels at a Veterans Affairs Medical Center.”, Eastern States Conference, 2013
Rattu MA, Marzella N, Mast A, et al. , “Evaluation of chronic oral phenytoin therapy and its effects on serum calcium and vitamin D levels at a Veterans Affairs Medical Center.”, Poster 7-145). ASHP 2012 Midyear Clinical Meeting. Las Vegas, Nevada., 2012
Billedo J, Chung E, Ho C, Marzella N.., “Evaluation of triglyceride management in patients on antiretroviral therapy at New York Harbor Healthcare System.”, Eastern States Conference, Hershey, Pennsylvania., 2012
Professional Affiliations
American Society of Health System Pharmacists (ASHP)
American Pharmaceutical Association (APhA)
American College of Clinical Pharmacy (ACCP)
American Association of Colleges of Pharmacy (AACP)
Honorary Inductee into the Phi-Lambda Sigma Pharmacy Leadership Society – Beta Kappa Chapter
